Glaxosmithkline Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue1,0141,0731,031982.201,256
Expenses662.15691.43658.15659.75797.01
EBITDA369.30403.46386.88339.26474.85
EBIT354.51401.12373.71323.42459.83
Profit Before Tax354.00399.93373.10322.45459.34
Net Profit257.49295.62277.86237.18335.88
Financial Ratios
Operating Profit Margin37.96%40.47%38.87%36.15%40.12%
Net Profit Margin26.08%27.11%27.92%25.27%28.38%
Earning Per Share (Diluted)15.0217.4516.4014.0019.83
Dividends Per Share0.000.000.000.000.00